C4 Therapeutics, Inc. (CCCC)

CCCC Revenue & Earnings

C4 Therapeutics, Inc. (CCCC) reported revenue of $35.95M and net income of $-104,994,000 for FY 2025, with a net profit margin of -292.1%. Revenue represents total sales while net income is the profit remaining after all expenses. The relationship between them reflects overall profitability.